Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
48
TLRY Quote, Financials, Valuation and Earnings
Last price:
$0.61
Seasonality move
:
147.52%
Day range:
$0.59 - $0.62
52-week range:
$0.35 - $2.15
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.63x
P/B ratio:
0.23x
Volume:
23.4M
Avg. volume:
36.3M
1-year change:
-68.77%
Market cap:
$619.9M
Revenue:
$788.9M
EPS (TTM):
-$1.05
Analysts' Opinion
-
Consensus RatingTilray Brands has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $1.22, Tilray Brands has an estimated upside of 101.59% from its current price of $0.60.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $0.60 representing 0.45% downside risk from its current price of $0.60.
Fair Value
-
According to the consensus of 10 analysts, Tilray Brands has 101.59% upside to fair value with a price target of $1.22 per share.
TLRY vs. S&P 500
-
Over the past 5 trading days, Tilray Brands has underperformed the S&P 500 by -10.78% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Tilray Brands does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Tilray Brands revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Tilray Brands reported revenues of $185.8M.
Earnings Growth
-
Tilray Brands earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Tilray Brands reported earnings per share of -$0.87.
Enterprise value:
620.9M
EV / Invested capital:
--
Price / LTM sales:
0.63x
EV / EBIT:
--
EV / Revenue:
0.75x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-7.11x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$255.3M
Return On Assets:
-23.3%
Net Income Margin (TTM):
-114.4%
Return On Equity:
-28.79%
Return On Invested Capital:
-26.19%
Operating Margin:
-16.9%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-02-28 | 2024-02-28 | 2025-02-28 | 2024-02-28 | 2025-02-28 | |
| Income Statement | ||||||
| Revenue | $596.3M | -- | $826.7M | -- | $185.8M | |
| Gross Profit | $73.1M | -- | $255.3M | -- | $52M | |
| Operating Income | -$258.4M | -- | -$105.8M | -- | -$31.4M | |
| EBITDA | -$1.6B | -- | -$772.9M | -- | -$750.4M | |
| Diluted EPS | -$3.04 | -- | -$1.05 | -- | -$0.87 | |
| Period Ending | 2021-02-28 | 2022-02-28 | 2023-02-28 | 2024-02-28 | 2025-02-28 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $573.4M | $695.8M | $758.5M | -- | $686.3M | |
| Total Assets | $2.2B | $5.8B | $4.4B | -- | $3.4B | |
| Current Liabilities | $170.3M | $282.4M | $469.7M | -- | $262.2M | |
| Total Liabilities | $972.3M | $1.2B | $969.1M | -- | $701M | |
| Total Equity | $1.2B | $4.7B | $3.4B | -- | $2.7B | |
| Total Debt | $692.1M | $710M | $592.6M | -- | $277.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-02-28 | 2024-02-28 | 2025-02-28 | 2024-02-28 | 2025-02-28 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$56.2M | -- | -$51.1M | -- | -$5.8M | |
| Cash From Investing | -$282.4M | -- | -$15.2M | -- | -$119K | |
| Cash From Financing | $225.7M | -- | $123.9M | -- | $18.1M | |
| Free Cash Flow | -$70.2M | -- | -$87.4M | -- | -$20.2M | |
TLRY
Sector
Market Cap
$619.9M
$34.4M
Price % of 52-Week High
28.03%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
-15.78%
-1.01%
1-Year Price Total Return
-68.77%
-37.36%
Beta (5-Year)
1.817
0.614
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.60
200-day SMA
Sell
Level
$0.95
Bollinger Bands (100)
Buy
Level
0.4 - 0.66
Chaikin Money Flow
Buy
Level
84.2M
20-day SMA
Buy
Level
$0.49
Relative Strength Index (RSI14)
Buy
Level
60.16
ADX Line
Buy
Level
30.53
Williams %R
Neutral
Level
-31.7605
50-day SMA
Buy
Level
$0.45
MACD (12, 26)
Buy
Level
0.17
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Neutral
Level
150.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.4102)
Buy
CA Score
(Annual)
Level (0.7383)
Buy
Beneish M-Score
(Annual)
Level (-2.4849)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (1.0776)
Buy
Piotroski F Score
(Annual)
Level (7)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
Stock Forecast FAQ
In the current month, TLRY has received 4 Buy ratings 6 Hold ratings, and 0 Sell ratings. The TLRY average analyst price target in the past 3 months is $1.22.
-
Where Will Tilray Brands Stock Be In 1 Year?
According to analysts, the consensus estimate is that Tilray Brands share price will rise to $1.22 per share over the next 12 months.
-
What Do Analysts Say About Tilray Brands?
Analysts are divided on their view about Tilray Brands share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Tilray Brands is a Sell and believe this share price will drop from its current level to $0.60.
-
What Is Tilray Brands's Price Target?
The price target for Tilray Brands over the next 1-year time period is forecast to be $1.22 according to 10 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is TLRY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Tilray Brands is a Hold. 6 of 10 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of TLRY?
You can purchase shares of Tilray Brands via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Tilray Brands shares.
-
What Is The Tilray Brands Share Price Today?
Tilray Brands was last trading at $0.61 per share. This represents the most recent stock quote for Tilray Brands. Yesterday, Tilray Brands closed at $0.60 per share.
-
How To Buy Tilray Brands Stock Online?
In order to purchase Tilray Brands stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
